Inhibition of myeloid cell leukemia-1 by tolfenamic acid induces apoptosis in mucoepidermoid carcinoma

Oral Diseases

Volumn 17, Issue 5, 2011, Pages 469-475

  Choi, K H ^a   Shim, J H ^a   Huong, L D ^a   Cho, N P ^a   Cho, S D ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Apoptosis; Myeloid cell leukemia 1; Salivary mucoepidermoid carcinoma; Tolfenamic acid

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4',6 DIAMIDINO 2 PHENYLINDOLE; AMPIROXICAM; CASPASE 3; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID CELL LEUKEMIA 1; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN BCL 2; SMALL INTERFERING RNA; TOLFENAMIC ACID; UNCLASSIFIED DRUG;

ADENOSQUAMOUS CARCINOMA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL POPULATION; CONCENTRATION RESPONSE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND CARCINOMA; WESTERN BLOTTING;

ANTHRANILIC ACIDS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, MUCOEPIDERMOID; CASPASE 3; CELL NUCLEUS; CELL PROLIFERATION; COLORING AGENTS; CYCLOOXYGENASE INHIBITORS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G1 PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEIC ACID SYNTHESIS INHIBITORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLICAMYCIN; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SALIVARY GLAND NEOPLASMS; SP1 TRANSCRIPTION FACTOR; TETRAZOLIUM SALTS; THIAZINES; THIAZOLES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 79957962723     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2010.01774.x     Document Type: Article

References (28)

1. Abdelrahim M, Baker CH, Abbruzzese JL et al (2007). Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells. Cancer Res 67: 3286-3294.
2. Agrawal A, Fentiman IS (2008). NSAIDs and breast cancer: a possible prevention and treatment strategy. Int J Clin Pract 62: 444-449.
3. Craig RW (2002). MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia 16: 444-454.
4. Das S, Kalyani R (2008). Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid. Indian J Pathol Microbiol 51: 34-36.
5. Ding Q, Huo L, Yang JY et al (2008). Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer. Cancer Res 68: 6109-6117.
6. Gojo I, Zhang B, Fenton RG (2002). The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1. Clin Cancer Res 8: 3527-3538.
7. Hao Y, Xie T, Korotcov A et al (2009). Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathways. Int J Cancer 124: 2200-2209.
8. Kaufmann SH, Karp JE, Letendre L et al (2005). Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemia. Clin Cancer Res 11: 6641-6649.
9. Kim YY, Lee EJ, Kim YK et al (2010). Anti-cancer effects of celecoxib in head and neck carcinoma. Mol Cells 29: 185-194.
10. Konduri S, Colon J, Baker CH et al (2009). Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression. Mol Cancer Ther 8: 533-542.
11. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW (1993). MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA 90: 3516-3520.
12. Kuroda J, Kamitsuji Y, Kimura S et al (2008). Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and beta-catenin. Int J Hematol 87: 507-515.
13. Lee EJ, Kim J, Lee SA et al (2005). Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells. Exp Mol Med 37: 379-390.
14. Leong SC, Pinder E, Sasae R, Mortimore S (2007). Mucoepidermoid carcinoma of the tongue. Singapore Med J 48: e272-e274.
15. Menzel T, Schauber J, Kreth F et al (2002). Butyrate and aspirin in combination have an enhanced effect on apoptosis in human colorectal cancer cells. Eur J Cancer Prev 11: 271-281.
16. Nagata M, Wada K, Nakajima A et al (2009). Role of myeloid cell leukemia-1 in cell growth of squamous cell carcinoma. J Pharmacol Sci 110: 344-353.
17. Papineni S, Chintharlapalli S, Abdelrahim M et al (2009). Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met. Carcinogenesis 30: 1193-1201.
18. Park IS, Jo JR, Hong H et al (2010). Aspirin induces apoptosis in YD-8 human oral squamous carcinoma cells through activation of caspases, down-regulation of Mcl-1, and inactivation of ERK-1/2 and AKT. Toxicol In Vitro 24: 713-720.
19. Saxena A, Moshynska OV, Moshynskyy ID et al (2007). Short nucleotide polymorphic insertions in the MCL-1 promoter affect gene expression. Cancer Lett 251: 114-131.
20. Selzer E, Thallinger C, Hoeller C et al (2002). Betulinic acid-induced Mcl-1 expression in human melanoma - mode of action and functional significance. Mol Med 8: 877-884.
21. Spiro RH (1986). Salivary neoplasms: overview of a 35-year experience with 2, 807 patients. Head Neck Surg 8: 177-184.
22. Takeda Y, Kurose A (2006). Pigmented mucoepidermoid carcinoma, a case report and review of the literature on melanin-pigmented salivary gland tumors. J Oral Sci 48: 253-256.
23. Tang R, Faussat AM, Majdak P et al (2006). Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells. Mol Cancer Ther 5: 723-731.
24. Tucci R, Matizonkas-Antonio LF, de Carvalhosa AA, Castro PH, Nunes FD, Pinto DD Jr (2009). Central mucoepidermoid carcinoma: report of a case with 11years' evolution and peculiar macroscopical and clinical characteristics. Med Oral Patol Oral Cir Bucal 14: E283-E286.
25. Ye X, Zhou W, Li Y et al (2010). Darbufelone, a novel anti-inflammatory drug, induces growth inhibition of lung cancer cells both in vitro and in vivo. Cancer Chemother Pharmacol 66: 277-285.
26. Zhang X, Morham SG, Langenbach R, Young DA (1999). Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J Exp Med 190: 451-459.
27. Zhang Z, Huang L, Zhao W, Rigas B (2010). Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res 70: 2379-2388.
28. Zhou P, Qian L, Kozopas KM, Craig RW (1997). Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood 89: 630-643.